Insulin resistance: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
(One intermediate revision by one other user not shown) | |||
Line 14: | Line 14: | ||
}} | }} | ||
{{Insulin resistance}} | {{Insulin resistance}} | ||
{{CMG}} | {{CMG}} {{AE}} {{DD}} | ||
== [[Insulin resistance overview|Overview]] == | == [[Insulin resistance overview|Overview]] == | ||
Line 43: | Line 43: | ||
== Case Studies == | == Case Studies == | ||
[[Insulin resistance case study one|Case #1]] | |||
==Related Chapters== | ==Related Chapters== | ||
* [[Chronic Somogyi rebound]] | * [[Chronic Somogyi rebound]] | ||
* [[Metabolic syndrome]] | * [[Metabolic syndrome]] |
Latest revision as of 05:13, 8 July 2014
Insulin resistance | ||
MeSH | C18.452.394.968.500 |
Insulin resistance Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Insulin resistance On the Web |
American Roentgen Ray Society Images of Insulin resistance |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Dayana Davidis, M.D. [2]
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Insulin Resistance from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications, and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies